Skip to content

Individual music therapy and wellbeing in dementia

Individual music therapy and wellbeing in nursing home residents with dementia A study protocol of a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25091
Enrollment
80
Registered
2019-05-04
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Interventions

Intervention group (MT) group A: receive 30 minutes of individual music therapy twice a week for 12 weeks in their own room. Music therapy treatment requires a qualified music therapist and can be de

Sponsors

Alzheimer nederland
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1- A chart diagnosis of dementia, which is usually according to Diagnostic and Statistical Manual of Mental Disorders IV criteria (American psychiatric association, 2001). 2-Clinically relevant NPS measured with the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) with the Frequency X Severity item score for at least one individual item = 4

Exclusion criteria

Exclusion criteria: 1- Residents who have received individual music therapy before and residents who have participated in group music therapy in the last 3 months. 2- Major comorbid psychiatric diagnosis (i.e. schizophrenia, psychosis, anxiety disorders). Depression is part of the NPI and patients with a history of depression will not be excluded. Residents with a hearing impairment that considerably impairs hearing, speech or music played at a moderately volume. We will use item 1a of the Severe Dual Sensory Loss in old age screening tool (SDSL)42. SDSL was found a valid and reliable

Design outcomes

Primary

MeasureTime frame
Well-being is measured by a blinded research assistant at baseline, six weeks and twelve weeks, during 5 minutes before and after the intervention session or individual attention session with the Discomfort Scale - Dementia of Alzheimer Type (DS-DAT).

Secondary

MeasureTime frame
Secondary outcomes include pain, quality of life, neuropsychiatric symptoms, anxiety, agitation, symptoms of depression, quality of sleep and psychotropic drug use.

Contacts

Public ContactVanusa Baroni Caramel

Amstelring

v.m.baroni.caramel@umcg.nl0626710128

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026